{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:21:54Z","timestamp":1787984514163,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antiretroviral therapy (ART) has transformed HIV infection from a fatal disease into a chronic condition and improved the life expectancy of people living with HIV (PLWH). Few studies have examined long-term changes in standardized mortality ratios (SMRs) by age and cause of death among PLWH in Japan. This study investigated the changes in SMR among men with HIV infection in Japan over an 18-year period, focusing on age at death and the contribution of malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of men with HIV infection who received care at Osaka National Hospital between 2007 and 2024. Data were extracted from medical records. Causes of death were classified according to the Coding Causes of Death in HIV protocol. SMRs were calculated based on the general male population of Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3,793 patients were included with 35,007 person-years of follow-up. The median age on enrollment was 36.3\u2009years, and the median follow-up period was 10.1\u2009years. Of the patients, 230 died during the study period, with a median age at death of 53.4\u2009years. The causes of death included 44 deaths from AIDS-defining illnesses, 20 deaths from AIDS-defining malignancies, 51 deaths from non-AIDS-defining malignancies; and 57 deaths of unknown cause. The SMR decreased from 4.11 in 2007\u20132011 to 1.27 in 2021\u20132024, with different patterns in different age groups. In recent years, the SMR in younger and older age groups approached that of the general population, but remained high in the 40\u201364-years age group, and in patients with CD4 counts\u2009&lt;\u2009200 cells\/\u03bcL or viral loads \u22651000 copies\/mL within the calendar year. The SMR for malignancies also remained high in the 40\u201364-years age group (2.28 in 2021\u20132024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among men with HIV infection in Japan, the risk of death has declined markedly with the widespread use of ART, approaching that of the general population, particularly in younger and older age groups. However, elevated mortality due to non-AIDS-related causes, particularly malignancies, persists among middle-aged men. Future HIV care should prioritize viral suppression and enhancing age-appropriate cancer screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12114-8","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:05:32Z","timestamp":1764943532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The shifting burden of mortality among men with HIV in Japan between 2007 and 2024: a single-center retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Keiji","family":"Konishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Uehira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ueji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Shirasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"12114_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","author":"Antiretroviral Therapy Cohort Collaboration","year":"2008","unstructured":"Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293\u201399.","journal-title":"Lancet"},{"key":"12114_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jiac.2021.02.003","volume":"27","author":"H Tsuda","year":"2021","unstructured":"Tsuda H, Koga M, Nojima M, Senkoji T, Kubota M, Kikuchi T, et al. Changes in survival and causes of death among people living with HIV: three decades of surveys from Tokyo, one of the Asian metropolitan cities. J Infect Chemother. 2021;27:949\u201356.","journal-title":"J Infect Chemother"},{"key":"12114_CR3","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S2352-3018(23)00272-2","volume":"11","author":"A Trickey","year":"2024","unstructured":"Trickey A, McGinnis K, Gill MJ, Abgrall S, Berenguer J, Wyen C, et al. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies. Lancet HIV. 2024;11:e176\u201385.","journal-title":"Lancet HIV"},{"key":"12114_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120\u201326.","journal-title":"Clin Infect Dis"},{"key":"12114_CR5","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/cid\/cir626","volume":"53","author":"B Hasse","year":"2011","unstructured":"Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the swiss HIV cohort study. Clin Infect Dis. 2011;53:1130\u201339.","journal-title":"Clin Infect Dis"},{"key":"12114_CR6","doi-asserted-by":"publisher","first-page":"e104945","DOI":"10.1371\/journal.pone.0104945","volume":"9","author":"PY Wu","year":"2014","unstructured":"Wu PY, Chen MY, Hsieh SM, Sun HY, Tsai MS, Lee KY, et al. Comorbidities among the HIV-infected patients aged 40 years or older in Taiwan. PLoS One. 2014;9:e104945.","journal-title":"PLoS One"},{"key":"12114_CR7","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"R Weber","year":"2006","unstructured":"Weber R, Sabin CA, Friis-M\u00f8ller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study. Arch Intern Med. 2006;166:1632\u201341.","journal-title":"Arch Intern Med"},{"key":"12114_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7326\/0003-4819-145-6-200609190-00003","volume":"145","author":"JE Sackoff","year":"2006","unstructured":"Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397\u2013406.","journal-title":"Ann Intern Med"},{"key":"12114_CR9","unstructured":"GBD. Causes of death collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2017. 2018;392:1736\u201388."},{"key":"12114_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/cid\/ciae014","volume":"79","author":"MSR Weber","year":"2024","unstructured":"Weber MSR, Duran Ramirez JJ, Hentzien M, Cavassini M, Bernasconi E, Hofmann E, et al. Time trends in causes of death in people with HIV: insights from the swiss HIV cohort study. Clin Infect Dis. 2024;79:177\u201388.","journal-title":"Clin Infect Dis"},{"key":"12114_CR11","doi-asserted-by":"publisher","first-page":"18161","DOI":"10.1007\/s00432-023-05500-9","volume":"149","author":"I Su\u00e1rez-Garc\u00eda","year":"2023","unstructured":"Su\u00e1rez-Garc\u00eda I, Gutierrez F, P\u00e9rez-Molina JA, Moreno S, Aldamiz T, Valencia Ortega E, et al. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up. J Cancer Res Clin Oncol. 2023;149:18161\u201371.","journal-title":"J Cancer Res Clin Oncol"},{"key":"12114_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/COH.0000000000000076","volume":"9","author":"D Costagliola","year":"2014","unstructured":"Costagliola D. Demographics of HIV and aging. Curr Opin HIV AIDS. 2014;9:294\u2013301.","journal-title":"Curr Opin HIV AIDS"},{"key":"12114_CR13","doi-asserted-by":"publisher","first-page":"e207954","DOI":"10.1001\/jamanetworkopen.2020.7954","volume":"3","author":"JL Marcus","year":"2020","unstructured":"Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000\u20132016. JAMA Netw Open. 2020;3:e207954.","journal-title":"JAMA Netw Open"},{"key":"12114_CR14","doi-asserted-by":"publisher","first-page":"e208023","DOI":"10.1001\/jamanetworkopen.2020.8023","volume":"3","author":"LF Collins","year":"2020","unstructured":"Collins LF, Armstrong WS. What it means to age with HIV infection: years gained are not comorbidity free. JAMA Netw Open. 2020;3:e208023.","journal-title":"JAMA Netw Open"},{"key":"12114_CR15","unstructured":"AIDS Prevention Information Network. The AIDS surveillance committee, the Japanese ministry of health, labour and welfare. Japanese. https:\/\/api-net.jfap.or.jp\/status\/japan\/nenpo.html. Accessed 13 July 2025."},{"key":"12114_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/eurpub\/ckae031","volume":"34","author":"A Vall\u00e9e","year":"2024","unstructured":"Vall\u00e9e A, Majerholc C, Zucman D, Livrozet JM, Laurendeau C, Bou\u00e9e S, et al. Mortality and comorbidities in a nationwide cohort of HIV-infected adults: comparison to a matched non-HIV adults\u2019 cohort, France, 2006\u201318. Eur J Public Health. 2024;34:879\u201384.","journal-title":"Eur J Public Health"},{"key":"12114_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.35772\/ghm.2019.01030","volume":"2","author":"S Oka","year":"2020","unstructured":"Oka S, Ikeda K, Takano M, Ogane M, Tanuma J, Tsukada K, et al. Pathogenesis, clinical course, and recent issues in HIV-1-infected Japanese hemophiliacs: a three-decade follow-up. Glob Health Med. 2020;2:9\u201317.","journal-title":"Glob Health Med"},{"key":"12114_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/QAD.0000000000002498","volume":"34","author":"T Nishijima","year":"2020","unstructured":"Nishijima T, Inaba Y, Kawasaki Y, Tsukada K, Teruya K, Kikuchi Y, et al. Mortality and causes of death in people living with hiv in the era of combination antiretroviral therapy compared with the general population in Japan. AIDS. 2020;34:913\u201321.","journal-title":"Aids"},{"key":"12114_CR19","unstructured":"Copenhagen HIV Programme (CHIP). Coding causes of death in HIV protocol; version 2.3; 2013 August. https:\/\/chip.dk\/media\/r3iddo35\/code-protocol-23.pdf. Accessed 13 Jul 2025."},{"key":"12114_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/EDE.0b013e31821b5332","volume":"22","author":"JD Kowalska","year":"2011","unstructured":"Kowalska JD, Friis-M\u00f8ller N, Kirk O, Bannister W, Mocroft A, Sabin C, et al. The coding causes of death in HIV (CoDe) project: initial results and evaluation of methodology. Epidemiology. 2011;22:516\u201323.","journal-title":"Epidemiology"},{"key":"12114_CR21","unstructured":"E-S. Statistics of Japan. Trends in deaths and death rates (per 100,000 population) by sex, age (5-year age groups) and causes of death: Japan. https:\/\/www.e-stat.go.jp\/en\/stat-search\/files?page=1%26layout=datalist%26toukei=00450011%26tstat=000001028897%26cycle=7%26year=20230%26month=0%26tclass1=000001053058%26tclass2=000001053061%26tclass3=000001053065%26result_back=1%26tclass4val=0. Accessed 13 July 2025."},{"key":"12114_CR22","doi-asserted-by":"publisher","first-page":"d6016","DOI":"10.1136\/bmj.d6016","volume":"343","author":"M May","year":"2011","unstructured":"May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: Uk collaborative HIV cohort (UK CHIC) study. BMJ. 2011;343:d6016.","journal-title":"BMJ"},{"key":"12114_CR23","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2468-2667(16)30020-2","volume":"2","author":"S Croxford","year":"2017","unstructured":"Croxford S, Kitching A, Desai S, Kall M, Edelstein M, Skingsley A, et al. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. Lancet Public Health. 2017;2:e35\u201346.","journal-title":"Lancet Public Health"},{"key":"12114_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/1471-2334-10-318","volume":"10","author":"FN Engsig","year":"2010","unstructured":"Engsig FN, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, R\u00f8ge B, et al. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC Infect Dis. 2010;10:318.","journal-title":"BMC Infect Dis"},{"key":"12114_CR25","unstructured":"Ministry of Health, Labour and Welfare. Reports on the certification of disabilities due to immune deficiency by HIV. https:\/\/www.mhlw.go.jp\/www1\/shingi\/s1216-3.html. Accessed 13 July 2025."},{"key":"12114_CR26","doi-asserted-by":"crossref","unstructured":"Fujiwara S, Nishiura H, Shirasaka T, Imamura A. Estimating undiagnosed HIV infections by age group in Japan: an extended age-dependent back-calculation. Infect Dis Model. 2025;10:1116\u201325.","DOI":"10.1016\/j.idm.2025.06.001"},{"key":"12114_CR27","doi-asserted-by":"crossref","unstructured":"Yuan T, Hu Y, Zhou X, Yang L, Wang H, Li L, et al. Incidence and mortality of non-AIDS-defining cancers among people living with HIV: a systematic review and meta-analysis. EClinicalMedicine. 2022;52:101613.","DOI":"10.1016\/j.eclinm.2022.101613"},{"key":"12114_CR28","doi-asserted-by":"crossref","unstructured":"Oka S, Ogata M, Takano M, Minamimoto R, Hotta M, Tajima T, et al. Non-AIDS-defining malignancies in Japanese hemophiliacs with HIV-1 infection. Glob Health Med. 2019;1:49\u201354.","DOI":"10.35772\/ghm.2019.01015"},{"key":"12114_CR29","doi-asserted-by":"crossref","unstructured":"Borges \u00c1H, Neuhaus J, Babiker AG, Henry K, Jain MK, Palfreeman A, et al. Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection. Clin Infect Dis. 2016;63:1668\u201376.","DOI":"10.1093\/cid\/ciw621"},{"key":"12114_CR30","doi-asserted-by":"crossref","unstructured":"Naito T, Suzuki M, Fukushima S, Yuda M, Fukui N, Tsukamoto S, et al. Comorbidities and co-medications among 28 089 people living with HIV: a nationwide cohort study from 2009 to 2019 in Japan. HIV Med. 2022;23:485\u201393.","DOI":"10.1111\/hiv.13206"},{"key":"12114_CR31","doi-asserted-by":"crossref","unstructured":"Naito T, Mori H, Fujibayashi K, Fukushima S, Yuda M, Fukui N, et al. Syphilis in people living with HIV does not account for the syphilis resurgence in Japan. J Infect Chemother. 2022;28:1494\u2013500.","DOI":"10.1016\/j.jiac.2022.07.017"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12114-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12114-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12114-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:04:24Z","timestamp":1781622264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12114-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12114"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12114-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7395984\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Osaka National Hospital (approval no. 25,034) and conducted in accordance with the principles of the Declaration of Helsinki. The requirement for individual informed consent was waived because the study was retrospective, and the data were anonymized prior to analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1694"}}